ALHC vs. GL, BNRE, VOYA, JXN, ESNT, ACT, OSCR, BWIN, FG, and PLMR
Should you be buying Alignment Healthcare stock or one of its competitors? The main competitors of Alignment Healthcare include Globe Life (GL), Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), Enact (ACT), Oscar Health (OSCR), Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), and Palomar (PLMR). These companies are all part of the "insurance" industry.
Alignment Healthcare vs. Its Competitors
Globe Life (NYSE:GL) and Alignment Healthcare (NASDAQ:ALHC) are both mid-cap insurance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.
81.6% of Globe Life shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 1.5% of Globe Life shares are owned by insiders. Comparatively, 7.0% of Alignment Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Globe Life has a net margin of 18.33% compared to Alignment Healthcare's net margin of -3.02%. Globe Life's return on equity of 21.44% beat Alignment Healthcare's return on equity.
In the previous week, Globe Life had 12 more articles in the media than Alignment Healthcare. MarketBeat recorded 15 mentions for Globe Life and 3 mentions for Alignment Healthcare. Globe Life's average media sentiment score of 0.24 beat Alignment Healthcare's score of 0.00 indicating that Globe Life is being referred to more favorably in the media.
Globe Life has higher revenue and earnings than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Globe Life, indicating that it is currently the more affordable of the two stocks.
Globe Life has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.
Globe Life presently has a consensus price target of $137.73, suggesting a potential upside of 13.64%. Alignment Healthcare has a consensus price target of $17.17, suggesting a potential upside of 20.72%. Given Alignment Healthcare's higher probable upside, analysts plainly believe Alignment Healthcare is more favorable than Globe Life.
Summary
Globe Life beats Alignment Healthcare on 11 of the 15 factors compared between the two stocks.
Get Alignment Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALHC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ALHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alignment Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:ALHC) was last updated on 7/3/2025 by MarketBeat.com Staff
